procarbazine has been researched along with Peritoneal Neoplasms in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, M | 1 |
| Tani, S | 1 |
| Hagihara, R | 1 |
| Ryu, Y | 1 |
| Yagi, N | 1 |
| Yamashita, J | 1 |
| Imanishi, K | 1 |
| Kitazawa, S | 1 |
1 other study available for procarbazine and Peritoneal Neoplasms
| Article | Year |
|---|---|
[A case of Hodgkin's disease of mesenteric origin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2002 |